About: Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $6.49 (-0.38%)
LFCR NASDAQ Lifecore Biomedical Inc.
Lifecore Biomedical Inc. share price
Atividade de preço de LFCR
Último preço
$ 6,490
Variação (24h)
-0,03 USD (0,38%)
Volume
48.78K
Volume (média 4 sem.)
-
Abertura
$ 6,52
Variação do dia
$ 6,47 - $ 6,52
Fechamento anterior
$ 6,51
Último negócio
29 Oct, 2:58 pm GMT+0
Atrasado
29 Oct, 2:58 pm GMT+0
LFCR price performance
Atrasado
29 Oct, 2:58 pm GMT+0
quote.marketSignals